Overview
Semilobar holoprosencephaly is a congenital brain malformation that represents an intermediate form of holoprosencephaly (HPE), a spectrum of defects resulting from incomplete division of the embryonic forebrain (prosencephalon) into two distinct cerebral hemispheres. In semilobar holoprosencephaly, the brain shows partial separation of the hemispheres posteriorly, but the frontal and parietal lobes remain fused, with incomplete formation of the interhemispheric fissure and partial or absent separation of the deep brain structures such as the thalami. The corpus callosum is typically absent or severely underdeveloped. This form is less severe than alobar holoprosencephaly (where there is no hemispheric division) but more severe than lobar holoprosencephaly. The condition primarily affects the central nervous system but frequently involves craniofacial structures as well. Key clinical features include intellectual disability of variable severity, seizures, motor impairment, and developmental delay. Craniofacial anomalies may include midface hypoplasia, cleft lip and/or palate, hypotelorism (closely spaced eyes), a flat nasal bridge, or a single central incisor. In some cases, more severe facial features such as cyclopia or proboscis may occur, though these are more commonly associated with the alobar form. Endocrine dysfunction, particularly diabetes insipidus and growth hormone deficiency related to hypothalamic-pituitary axis abnormalities, is also frequently observed. Feeding difficulties and temperature regulation problems may occur in infancy. Holoprosencephaly, including the semilobar form, can result from chromosomal abnormalities (such as trisomy 13), mutations in genes including SHH, ZIC2, SIX3, and TGIF1, or environmental factors such as maternal diabetes. There is no cure for semilobar holoprosencephaly. Treatment is supportive and symptomatic, focusing on seizure management with antiepileptic medications, hormone replacement therapy for endocrine deficiencies, surgical correction of craniofacial anomalies when appropriate, physical and occupational therapy, and nutritional support. Prognosis varies considerably depending on the degree of brain malformation and associated anomalies, with some individuals surviving into childhood or beyond with significant supportive care.
Clinical phenotype terms— hover any for plain English:
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Semilobar holoprosencephaly.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Semilobar holoprosencephaly at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Semilobar holoprosencephaly.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Semilobar holoprosencephaly.
Community
No community posts yet. Be the first to share your experience with Semilobar holoprosencephaly.
Start the conversation →Latest news about Semilobar holoprosencephaly
No recent news articles for Semilobar holoprosencephaly.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Semilobar holoprosencephaly
What is Semilobar holoprosencephaly?
Semilobar holoprosencephaly is a congenital brain malformation that represents an intermediate form of holoprosencephaly (HPE), a spectrum of defects resulting from incomplete division of the embryonic forebrain (prosencephalon) into two distinct cerebral hemispheres. In semilobar holoprosencephaly, the brain shows partial separation of the hemispheres posteriorly, but the frontal and parietal lobes remain fused, with incomplete formation of the interhemispheric fissure and partial or absent separation of the deep brain structures such as the thalami. The corpus callosum is typically absent or
At what age does Semilobar holoprosencephaly typically begin?
Typical onset of Semilobar holoprosencephaly is neonatal. Age of onset can vary across affected individuals.